Ratings by H.C. Wainwright (Robert Burns)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/22/2026 | Elicio Therapeutics | ELTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2026 | Karyopharm Therapeutics | KPTI | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2026 | Cogent | COGT | Maintain | Buy (Buy) |
|
Details | ||
| 6/16/2026 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (Buy) |
|
Details | ||
| 6/15/2026 | Elicio Therapeutics | ELTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2026 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2026 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2026 | ORIC Pharmaceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 6/8/2026 | ADC Therapeutics | ADCT | Downgrade | Neutral (Buy) |
1.03 (1.07) |
3.88% | Details | |
| 6/4/2026 | Radiopharm Theranostics | RADX | New Coverage | Buy (N/A) |
4.49 (4.14) |
-7.8% | Details | |
| 6/3/2026 | Akoustis Technologies | AKTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2026 | Cogent | COGT | Maintain | Buy (Buy) |
|
Details | ||
| 5/26/2026 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2026 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2026 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Telix Pharmaceuticals Ltd | TLX | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2026 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 4/28/2026 | Prelude Therapeutics | PRLD | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2026 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 4/24/2026 | BridgeBio Oncology Therapeutics, In | BBOT | Maintain | Buy (Buy) |
|
Details | ||
| 4/22/2026 | Molecular Partners | MOLN | Maintain | Buy (Buy) |
|
Details | ||
| 4/13/2026 | Telix Pharmaceuticals Ltd | TLX | Maintain | Buy (Buy) |
|
Details | ||
| 4/13/2026 | Replimune Group | REPL | Downgrade | Sell (Buy) |
4.76 (11.27) |
136.76% | Details | |
| 4/10/2026 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 4/10/2026 | Telix Pharmaceuticals Ltd | TLX | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2026 | Enliven Therapeutics | ELVN | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2026 | Telix Pharmaceuticals Ltd | TLX | Maintain | Buy (Buy) |
|
Details | ||
| 4/2/2026 | Cogent | COGT | Maintain | Buy (Buy) |
|
Details | ||
| 4/2/2026 | ORIC Pharmaceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2026 | Akoustis Technologies | AKTS | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2026 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2026 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | OnKure Therapeutics Inc. | OKUR | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2026 | Elicio Therapeutics | ELTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Akoustis Technologies | AKTS | New Coverage | Buy (N/A) |
18.81 (28.70) |
52.58% | Details | |
| 3/6/2026 | BridgeBio Oncology Therapeutics, In | BBOT | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2026 | ORIC Pharmaceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2026 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Exelixis | EXEL | Maintain | Buy (Buy) |
|
Details | ||
| 1/30/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Molecular Partners | MOLN | New Coverage | Buy (N/A) |
4.00 (3.80) |
-5% | Details | |
| 1/21/2026 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2026 | ORIC Pharmaceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 1/14/2026 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 1/14/2026 | Cogent | COGT | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | TuHURA Biosciences | HURA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | CytomX Therapeutics | CTMX | Maintain | Buy (Buy) |
|
Details | ||
| 12/1/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 11/21/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2025 | ORIC Pharmaceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 10/20/2025 | Bolt Biotherapeutics, Inc. | BOLT | New Coverage | Buy (N/A) |
5.75 (5.28) |
-8.17% | Details | |
| 10/16/2025 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2025 | Karyopharm Therapeutics | KPTI | Upgrade | Buy (Neutral) |
5.50 (9.12) |
65.82% | Details | |
| 10/3/2025 | Perspective Therapeutics Inc | CATX | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2025 | ADC Therapeutics | ADCT | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Prelude Therapeutics | PRLD | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2025 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 9/15/2025 | BridgeBio Oncology Therapeutics, In | BBOT | New Coverage | Buy (N/A) |
0.00 (7.44) |
0% | Details | |
| 9/12/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2025 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Telix Pharmaceuticals Ltd | TLX | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (Buy) |
|
Details | ||
| 8/22/2025 | TuHURA Biosciences | HURA | Maintain | Buy (Buy) |
|
Details | ||
| 8/22/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2025 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
7.47 (17.65) |
136.28% | Details | |
| 8/12/2025 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Y-mAbs Therapeutics | YMAB | Downgrade | Neutral (Buy) |
8.52 (8.61) |
1.06% | Details | |
| 7/23/2025 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
0.75 (8.25) |
1000% | Details | |
| 7/22/2025 | ArriVent BioPharma | AVBP | Maintain | Buy (Buy) |
|
Details | ||
| 7/17/2025 | Elicio Therapeutics | ELTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2025 | Karyopharm Therapeutics | KPTI | Downgrade | Neutral (Buy) |
4.24 (5.50) |
29.72% | Details | |
| 7/14/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2025 | Karyopharm Therapeutics | KPTI | New Coverage | Buy (N/A) |
5.00 (9.12) |
82.4% | Details | |
| 7/8/2025 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (Buy) |
|
Details | ||
| 7/3/2025 | Telix Pharmaceuticals Ltd | TLX | New Coverage | Buy (N/A) |
16.50 (10.90) |
-33.94% | Details | |
| 7/2/2025 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | TuHURA Biosciences | HURA | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | ArriVent BioPharma | AVBP | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2025 | Exelixis | EXEL | Maintain | Buy (Buy) |
|
Details | ||
| 6/13/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 6/12/2025 | Exelixis | EXEL | Maintain | Buy (Buy) |
|
Details | ||
| 6/4/2025 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2025 | ORIC Pharmaceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 5/21/2025 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2025 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2025 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2025 | CytomX Therapeutics | CTMX | Upgrade | Buy (Neutral) |
2.38 (3.32) |
39.5% | Details | |
| 5/14/2025 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2025 | Spring Works Therapeutics | SWTX | Downgrade | Neutral (Buy) |
46.24 (46.99) |
1.62% | Details | |
| 4/28/2025 | Spring Works Therapeutics | SWTX | Maintain | Buy (Buy) |
|
Details | ||
| 4/28/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2025 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 4/3/2025 | TuHURA Biosciences | HURA | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2025 | Exelixis | EXEL | Maintain | Buy (Buy) |
|
Details | ||
| 3/18/2025 | OnKure Therapeutics Inc. | OKUR | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2025 | Perspective Therapeutics Inc | CATX | New Coverage | Buy (N/A) |
2.66 (3.00) |
12.78% | Details | |
| 3/10/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | ArriVent BioPharma | AVBP | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2025 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | TuHURA Biosciences | HURA | New Coverage | Buy (N/A) |
2.41 (2.52) |
4.56% | Details | |
| 2/11/2025 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2025 | ORIC Pharamceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 1/30/2025 | Cargo Therapeutics | CRGX | Downgrade | Neutral (Buy) |
13.19 (4.47) |
-66.11% | Details | |
| 1/29/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Atara Biotherapeutics | ATRA | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/27/2025 | Exelixis | EXEL | Maintain | Buy (Buy) |
|
Details | ||
| 1/27/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2025 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | CytomX Therapeutics | CTMX | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/6/2025 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2025 | ADC Therapeutics | ADCT | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2025 | Nuvation Bio Inc | NUVB | Maintain | Buy (Buy) |
|
Details | ||
| 12/11/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2024 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
19.54 (25.64) |
31.22% | Details | |
| 12/4/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2024 | Cogent | COGT | Maintain | Buy (Buy) |
|
Details | ||
| 10/28/2024 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2024 | OnKure Therapeutics Inc. | OKUR | New Coverage | Buy (N/A) |
18.59 (4.34) |
-76.65% | Details | |
| 10/14/2024 | Relay Therapeutics | RLAY | Maintain | Buy (Buy) |
|
Details | ||
| 10/3/2024 | Immix Biopharma, Inc. | IMMX | Maintain | Buy (Buy) |
|
Details | ||
| 10/2/2024 | Enliven Therapeutics | ELVN | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2024 | Repare Therapeutics | RPTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2024 | ORIC Pharamceuticals | ORIC | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2024 | Prelude Therapeutics | PRLD | Upgrade | Buy (Neutral) |
2.44 (4.27) |
75% | Details | |
| 9/16/2024 | Exelixis | EXEL | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2024 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2024 | CytomX Therapeutics | CTMX | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/10/2024 | Prelude Therapeutics | PRLD | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/10/2024 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2024 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
21.44 (47.77) |
122.81% | Details | |
| 9/5/2024 | IGM Biosciences | IGMS | Maintain | Neutral (N/A) |
|
Details | ||
| 9/4/2024 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (Buy) |
|
Details | ||
| 9/4/2024 | Repare Therapeutics | RPTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/4/2024 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2024 | Spring Works Therapeutics | SWTX | Maintain | Buy (Buy) |
|
Details | ||
| 8/21/2024 | Aadi Bioscience Inc | AADI | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/16/2024 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Cargo Therapeutics | CRGX | New Coverage | Buy (N/A) |
15.83 (13.19) |
-16.68% | Details | |
| 7/17/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2024 | Immix Biopharma, Inc. | IMMX | New Coverage | Buy (N/A) |
1.98 (10.04) |
407.07% | Details | |
| 6/27/2024 | CytomX Therapeutics | CTMX | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/18/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2024 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | Apollomics Inc. | APLM | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Kronos Bio Inc. | KRON | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2024 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
16.34 (32.02) |
95.96% | Details | |
| 4/1/2024 | Apollomics Inc. | APLM | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2024 | Calidi Biotherapeutics Inc | CLDI | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2024 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2024 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | IGM Biosciences | IGMS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/7/2024 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Prelude Therapeutics | PRLD | Downgrade | Neutral (Buy) |
4.63 (4.27) |
-7.78% | Details | |
| 2/14/2024 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2024 | Elicio Therapeutics | ELTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | Portage Biotech inc. | PRTG | Downgrade | Neutral (Buy) |
1.09 (6.81) |
524.77% | Details | |
| 1/5/2024 | Viracta Therapeutics | VIRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2023 | Kronos Bio Inc. | KRON | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Aadi Bioscience Inc | AADI | Downgrade | Neutral (Buy) |
5.37 (2.05) |
-61.82% | Details | |
| 12/13/2023 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2023 | IGM Biosciences | IGMS | Downgrade | Neutral (Buy) |
6.48 (1.27) |
-80.4% | Details | |
| 11/30/2023 | Portage Biotech inc. | PRTG | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2023 | Calidi Biotherapeutics Inc | CLDI | New Coverage | Buy (N/A) |
1.70 (0.16) |
-90.59% | Details | |
| 11/20/2023 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2023 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Omega Therapeutics | OMGA | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Aadi Bioscience Inc | AADI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Atara Biotherapeutics | ATRA | Downgrade | Neutral (Buy) |
1.21 (10.55) |
771.9% | Details | |
| 11/7/2023 | Prelude Therapeutics | PRLD | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2023 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2023 | Elicio Therapeutics | ELTX | New Coverage | Buy (N/A) |
6.50 (3.98) |
-38.77% | Details | |
| 10/19/2023 | Prelude Therapeutics | PRLD | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2023 | Apollomics Inc. | APLM | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2023 | Exelixis | EXEL | New Coverage | Buy (N/A) |
21.83 (52.87) |
142.19% | Details | |
| 9/19/2023 | Kinnate Biopharma | KNTE | Downgrade | Neutral (Buy) |
1.70 (2.65) |
55.88% | Details | |
| 9/8/2023 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2023 | eFFECTOR Therapeutics, Inc. | EFTR | New Coverage | Buy (N/A) |
0.71 (0.18) |
-74.65% | Details | |
| 8/21/2023 | Kronos Bio Inc. | KRON | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Portage Biotech inc. | PRTG | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2023 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2023 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/5/2023 | Viracta Therapeutics | VIRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2023 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2023 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2023 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2023 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2023 | Apollomics Inc. | APLM | New Coverage | Buy (N/A) |
4.05 (20.50) |
406.17% | Details | |
| 5/18/2023 | Kinnate Biopharma | KNTE | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Viracta Therapeutics | VIRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | Kineta Inc. | KA | New Coverage | Buy (N/A) |
3.97 (0.57) |
-85.64% | Details | |
| 4/20/2023 | Kinnate Biopharma | KNTE | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2023 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Aadi Bioscience Inc | AADI | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Tango Therapeutics Inc. | TNGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2023 | Cogent | COGT | New Coverage | Buy (N/A) |
10.11 (37.53) |
271.22% | Details | |
| 3/20/2023 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Prelude Therapeutics | PRLD | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2023 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Omega Therapeutics | OMGA | New Coverage | Buy (N/A) |
6.30 (0.14) |
-97.78% | Details | |
| 12/1/2022 | Portage Biotech inc. | PRTG | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2022 | Ikena Oconology | IKNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2022 | Kronos Bio Inc. | KRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Prelude Therapeutics | PRLD | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Neoleukin Therapeutics | NLTX | Downgrade | Neutral (Buy) |
0.42 (3.49) |
730.95% | Details | |
| 11/7/2022 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2022 | Tango Therapeutics Inc. | TNGX | New Coverage | Buy (N/A) |
6.98 (29.12) |
317.19% | Details | |
| 10/7/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | Portage Biotech inc. | PRTG | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2022 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2022 | GT Biopharma Inc. | GTBP | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Neoleukin Therapeutics | NLTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2022 | Forma Therapeutics | FMTX | Downgrade | Neutral (Buy) |
20.24 (20.01) |
-1.14% | Details | |
| 8/18/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2022 | Kinnate Biopharma | KNTE | New Coverage | Buy (N/A) |
12.04 (2.65) |
-77.99% | Details | |
| 7/11/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2022 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2022 | CytomX Therapeutics | CTMX | Downgrade | Neutral (Buy) |
1.30 (3.32) |
155.38% | Details | |
| 6/6/2022 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2022 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2022 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
4.78 (6.46) |
35.15% | Details | |
| 4/14/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2022 | Portage Biotech inc. | PRTG | New Coverage | Buy (N/A) |
7.87 (6.81) |
-13.47% | Details | |
| 12/29/2021 | Nurix | NRIX | New Coverage | Buy (N/A) |
30.16 (19.30) |
-36.01% | Details | |
| 12/23/2021 | Ikena Oconology | IKNA | New Coverage | Buy (N/A) |
15.01 (1.43) |
-90.47% | Details | |
| 12/22/2021 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Autolus Therapeutics plc | AUTL | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Aadi Bioscience Inc | AADI | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | PMV Pharmaceuticals Inc. | PMVP | New Coverage | Buy (N/A) |
35.66 (1.18) |
-96.69% | Details | |
| 7/21/2021 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2021 | Aerpio Pharmaceuticals | ARPO | Upgrade | Buy (Neutral) |
1.71 (2.20) |
28.65% | Details | |
| 6/28/2021 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2021 | Kronos Bio Inc. | KRON | New Coverage | Buy (N/A) |
23.85 (0.88) |
-96.31% | Details | |
| 6/21/2021 | Molecular Partners | MOLN | New Coverage | Buy (N/A) |
19.26 (4.00) |
-79.23% | Details | |
| 5/24/2021 | GT Biopharma Inc. | GTBP | New Coverage | Buy (N/A) |
14.36 (0.46) |
-96.8% | Details | |
| 5/5/2021 | Atara Biotherapeutics | ATRA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2021 | Viracta Therapeutics | VIRX | New Coverage | Buy (N/A) |
10.80 (0.08) |
-99.26% | Details | |
| 4/26/2021 | ADC Technologies | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2021 | Prelude Therapeutics | PRLD | New Coverage | Buy (N/A) |
34.59 (4.27) |
-87.66% | Details | |
| 3/2/2021 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2020 | Autolus Therapeutics | AUTL | New Coverage | Buy (N/A) |
8.90 (1.59) |
-82.13% | Details | |
| 9/14/2020 | Immunomedics | IMMU | Downgrade | Neutral (Buy) |
42.25 (87.86) |
107.95% | Details | |
| 7/1/2020 | IGM Biosciences | IGMS | New Coverage | Buy (N/A) |
73.00 (1.27) |
-98.26% | Details | |
| 6/15/2020 | Atara Biotherapeutics | ATRA | New Coverage | Buy (N/A) |
9.38 (10.55) |
12.47% | Details | |
| 5/14/2020 | CytomX Therapeutics | CTMX | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2020 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2020 | Neoleukin Therapeutics | NLTX | New Coverage | Buy (N/A) |
11.35 (3.49) |
-69.25% | Details | |
| 1/28/2020 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details |
